Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Therapy”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)Study completedNCT03296553
What this trial is testing

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Who this might be right for
Kaposi SarcomaHuman Immunodeficiency VirusImmune Reconstitution Syndrome
National Institute of Cancerología 40
Testing effectiveness (Phase 2)Looking for participantsNCT07178431
What this trial is testing

MB-CART2019.1 in Refractory Multiple Sclerosis

Who this might be right for
Multiple SclerosisCAR T Cell Therapy
Miltenyi Biomedicine GmbH 26
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Not applicableStudy completedNCT02827227
What this trial is testing

Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)

Who this might be right for
HIV-infected Patients
Hospices Civils de Lyon 99
Testing effectiveness (Phase 2)Looking for participantsNCT06836505
What this trial is testing

Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.

Who this might be right for
Neuroblastoma (NB)Desmoplastic Small Round Cell Tumor (DSRCT)
Sun Yat-Sen University Cancer Center 10
Early research (Phase 1)WithdrawnNCT04556266
What this trial is testing

A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies

Who this might be right for
LeukemiaLymphomaLymphoma, B-Cell
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more
Beijing GoBroad Hospital 45
Not applicableLooking for participantsNCT07051525
What this trial is testing

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

Who this might be right for
LeukemiaCART TherapyTransplantation, Stem Cell+1 more
Peter MacCallum Cancer Centre, Australia 214
Very early researchTemporarily pausedNCT06586658
What this trial is testing

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Who this might be right for
Renal Cell Carcinoma
Shanghai Changzheng Hospital 9
Not applicableLooking for participantsNCT04300998
What this trial is testing

Study of CAR-T Therapy in Older Patients

Who this might be right for
LymphomaRefractory B-Cell LymphomaLymphoma, B-Cell+3 more
Memorial Sloan Kettering Cancer Center 154
Not applicableEnded earlyNCT03026829
What this trial is testing

Sound Therapy for Tinnitus Relief in Cochlear Implant Users

Who this might be right for
Tinnitus, Hearing Loss, Cochlear Implant Users
Cochlear 32
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Testing effectiveness (Phase 2)Looking for participantsNCT06267729
What this trial is testing

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 60
Early research (Phase 1)Looking for participantsNCT06709469
What this trial is testing

Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Instituto de Investigación Hospital Universitario La Paz 10
Not applicableStudy completedNCT01295034
What this trial is testing

Vitamin D Supplements for HIV-positive Patients on cART

Who this might be right for
HIV-associated Co-morbidities
Andrea Branch 62
Very early researchNot Yet RecruitingNCT06097455
What this trial is testing

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

Who this might be right for
Refractory Non-Hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma
Fundacion Clinic per a la Recerca Biomédica 40
Early research (Phase 1)Study completedNCT04768608
What this trial is testing

PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

Who this might be right for
Castrate-Resistant Prostate Cancer
Zhejiang University 3
Early research (Phase 1)UnknownNCT03767725
What this trial is testing

Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Shenzhen Second People's Hospital 10
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Not applicableStudy completedNCT05390671
What this trial is testing

CAR-T Cell Therapy in Patients With Hematological Malignancies

Who this might be right for
CART Therapy
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 260
Next Page